Literature DB >> 124324

Chronic mucocutaneous candidiasis with macrophage dysfunction, a plasma inhibitor, and co-existent aplastic anemia.

J J Twomey, C C Waddell, S Krantz, R O'reilly, P L'esperance, R A Good.   

Abstract

A 56-year-old man developed chronic mucocutaneous candidiasis (MCC) and pernicious anemia. Nine years later he developed aplastic anemia which ultimately was fatal. A small thymoma was found at autopsy. He was anergic and his mononuclear leukocytes (MNL) failed to undergo a proliferative response in culture to soluble antigens. His monocytes did not mediate a proliferative response by lymphocytes from sensitized control donors when stimulated with Monilia albicans antigen but did mediate a mixed leukocyte reaction normally. His plasma contained a poten inhibitor of -3H-thymidine incorporation by sensitized control MNL when stimulated with soluble antigens but was not inhibitory of the mixed leukocyte reaction, lymphoproliferative responses to plant mitogens, and was not shown either in vivo or in vitro to depress hematopoiesis. Patient lymphocytes were responsive to plant mitogens, Monilia antigen, in the mixed leukocyte reaction, and produced macrophage migration inhibitory factor in response to Monilia antigen. After plasmapheresis, delayed hypersensitivity and lymphoproliferative responses to soluble antigens were temporarily restored. This case implicates the macrophage in the pathogenesis of MCC and demonstrates some consequences of chronic monocyte dysfunction. The inhibitor of some expressions of cell-mediated immunity was removed by plasmapheresis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 124324

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  12 in total

1.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Bioassay determinations of thymopoietin and thymic hormone levels in human plasma.

Authors:  J J Twomey; G Goldstein; V M Lewis; P M Bealmear; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

3.  Plasma thymic hormone activity in patients with chronic mucocutaneous candidiasis.

Authors:  C H Kirkpatrick; L E Greenberg; S W Chapman; G Goldstein; V M Lewis; J J Twomey
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

Review 4.  Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.

Authors:  R D Nelson; N Shibata; R P Podzorski; M J Herron
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

5.  Characteristics of Candida albicans adherence to mouse tissues.

Authors:  J E Cutler; D L Brawner; K C Hazen; M A Jutila
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

Review 7.  Cutaneous defenses against dermatophytes and yeasts.

Authors:  D K Wagner; P G Sohnle
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

8.  Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.

Authors:  P L Fidel; M E Lynch; J D Sobel
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.

Authors:  A Fischer; J J Ballet; C Griscelli
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

10.  Inhibition of lymphoproliferation by hyperlipoproteinemic plasma.

Authors:  C C Waddell; O D Taunton; J J Twomey
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.